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Quantitative mass spectrometry has established
proteome-wide regulation of protein abundance
and post-translational modifications in various bio-
logical processes. Here, we used quantitative mass
spectrometry to systematically analyze the thermal
stability and solubility of proteins on a proteome-
wide scale during the eukaryotic cell cycle. We
demonstrate pervasive variation of these biophysical
parameters with most changes occurring in mitosis
and G1. Various cellular pathways and components
vary in thermal stability, such as cell-cycle fac-
tors, polymerases, and chromatin remodelers. We
demonstrate that protein thermal stability serves as
a proxy for enzyme activity, DNA binding, and com-
plex formation in situ. Strikingly, a large cohort of
intrinsically disordered and mitotically phosphory-
lated proteins is stabilized and solubilized in mitosis,
suggesting a fundamental remodeling of the bio-
physical environment of the mitotic cell. Our data
represent a rich resource for cell, structural, and sys-
tems biologists interested in proteome regulation
during biological transitions.
INTRODUCTION
Mass spectrometry (MS)-based proteomics is a powerful
method to accurately quantify distinct features of proteomes
(Mann et al., 2013) and has provided comprehensive insight
into the variability of protein abundance under distinct biological
conditions, including different cell types (Geiger et al., 2012),
protein complexes (Havugimana et al., 2012), and subcellular
fractions (Boisvert et al., 2010). Recent advances in MS multi-
plexing technologies (Werner et al., 2014) enable the global mea-
surement of protein melting curves (thermal proteome profiling;Cell 173, 1495–1507, M
This is an open access article undTPP) (Savitski et al., 2014). TPP and a partial digestion-based
methodology for assessing protein thermal stability (Leuen-
berger et al., 2017) add another dimension to MS-based prote-
omics to quantify various states of the proteome. TPP can detect
individual proteins that are stabilized in situ by binding to a ligand
and, therefore, is useful for profiling drug targets and off-targets
(Becher et al., 2016; Savitski et al., 2014). However, its utility to
uncover global changes in protein thermal stability in distinct bio-
logical contexts is unclear.
The eukaryotic cell cycle is the key regulatory circuit that
controls the temporal separation of fundamental processes
that facilitate cell proliferation. It is well established that various
aspects of proteome organization, including protein abun-
dance and post-translational modifications, vary during cell-
cycle progression (Dephoure et al., 2008; Olsen et al., 2010).
We hypothesized that cell-cycle-dependent post-translational
modifications, protein-protein interactions, and spatial rear-
rangements to distinct biophysical environments globally influ-
ence protein thermal stability (Jensen et al., 2006; Jongsma
et al., 2015; Olsen et al., 2010; Pelisch et al., 2014). Here, we
systematically measured in situ protein thermal stability, abun-
dance, and solubility during cell-cycle progression on a prote-
ome-wide scale.
We report the pervasive variation of protein thermal stability
during the cell cycle and link it to various biological processes
including transcription, spindle formation and key metabolic
pathways. Further, intrinsically disordered proteins are stabi-
lized during mitosis, coinciding with fundamental rearrange-
ments of the proteome and the spatial outline of the cell. These
changes coincide with extensive sumoylation and mitotic phos-
phorylation, suggesting that post-translational modifications
might promote thermal stability and, in turn, prevent protein ag-
gregation during mitotic spindle formation and chromosomal
separation. Protein stabilization serves as a proxy for biological
activity and complex formation, thereby revealing new players
in the cell cycle. Our comprehensive analysis of cell-cycle-
dependent variation of protein thermal stability, abundance,
and solubility provides a valuable resource to advance the fieldsay 31, 2018 ª 2018 The Author(s). Published by Elsevier Inc. 1495
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Profiling of Proteome Abundance and Stability Changes
across the Cell Cycle
HeLa cells were arrestedwith thymidine and/or nocodazole at six different cell-
cycle stages, and additionally asynchronous cells were collected. For TPP
experiments, intact cells were heated to ten different temperatures and lysed
with NP-40. After removing protein aggregates, the soluble fractions were
labeled with isobaric mass tags (TMT10-plex) for protein quantification.
Samples were combined using the TPP-TR layout (right panel) for melting
curve determination or in a 2D-TPP layout (left panel), in order to pool cell-cycle
stages from one thermal treatment, for sensitive comparison of protein
abundance and stability changes throughout the cell cycle. G1/S was used as
reference point for calculating fold changes (FC). By condensing this matrix to
two measures (abundance and stability scores), we identified significant
1496 Cell 173, 1495–1507, May 31, 2018of transcription, structural biology, intrinsically disordered pro-
teins, metabolism, and the cell cycle.
RESULTS
Profiling the Thermal Stability, Abundance, and
Solubility of Proteins during the Cell Cycle
To investigate proteome variation across different stages of the
cell cycle in situ, we used thermal proteome profiling (TPP) to
measure protein thermal stability and abundance (Savitski
et al., 2014). We synchronized and collected HeLa cells in six
different cell-cycle stages: G1/S transition (no release after
double thymidine block), early S phase (2 hr after release), late
S phase (4 hr after release), S/G2 transition (6 hr after release),
mitosis (0.5 hr after release from nocodazole block), and early
G1 phase (4.5 hr after release from nocodazole block). We also
collected asynchronous cells (Figures 1 and S1A–S1D; STAR
Methods). Intact cells were heated and lysed with a mild deter-
gent (NP-40), and soluble proteins were identified bymultiplexed
quantitative MS based on tandem mass tag (TMT) labeling
(Werner et al., 2014).
To derive changes in protein thermal stability and abun-
dance across cell-cycle stages, we used two-dimensional TPP
(2D-TPP), which multiplexes different cell-cycle stages at each
temperature (Becher et al., 2016) (see Figure 1; STAR Methods).
This analysis yields protein abundance ratios to the reference
condition, G1/S phase. We obtained quantitative data across
the different cell-cycle stages and temperatures for each of the
4,970 proteins that passed our quality control requirements
(see STAR Methods), out of the total set of 10,064 identified
proteins (Table S1). We calculated abundance and stability
scores for each protein and determined the significance based
on three biological replicates (see Figures 1 and 2A; Table S2;
STAR Methods).
Changes in protein abundance can reflect altered protein
levels or altered solubility, with the latter capturing e.g., a transi-
tion from a polymerized to a depolymerized state. To disentangle
these two possibilities, we also quantified the total amount of
protein in the cell after solubilizing with a strong detergent
(SDS) (Table S3).
To capture the shape of protein melting curves, we applied the
TPP temperature range (TPP-TR) approach to mitotic and G1/S
cells (Savitski et al., 2014); doing so multiplexes ten different
temperatures for each stage (Figure 1; Table S4). Hereafter, we
will use the term ‘‘stability’’ to refer to the thermal stability of pro-
teins, i.e., a protein becomes more stable if exposure to a higher
temperature is required in order to cause this protein to aggre-
gate inside the cell. We will use the term ‘‘solubility’’ to refer to
differences in the observed abundance of a protein in mild
(NP40) versus strong (SDS) detergent.
Overall, we generated a comprehensive catalog of protein
abundance, stability, and solubility, with detailed temporal cell-
cycle resolution.changes across the proteome and represented them as a circle plot for indi-
vidual proteins. Inner circle (orange), abundance changes; outer circle (purple),
stability changes.
See also Figure S1 and Table S1.
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Known Cell-Cycle Factors Show Changes in Stability
We explored our datasets for well-characterized cell-cycle fac-
tors. For instance, cyclin-A2 (CCNA2) varied in abundance, but
not in stability (Figures 2A and S1E). In contrast, cyclin-depen-
dent kinase 1 (CDK1) did not show significant changes in abun-
dance across the cell cycle (Malumbres and Barbacid, 2009), but
its thermal stability dramatically declined after G2 (Figures 2A
and S1E).
Strikingly, several proteins with functions relevant to the
cell cycle displayed altered stability rather than abundance
during the cell cycle (Figure 2B). Among these, we identified
S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1),
which inhibits ribonucleotide reductase large subunit (RRM1) in
a cell-cycle-dependent manner (Arnaoutov and Dasso, 2014);
the ATP-dependent DNA helicase Q1 (RECQL); and inosine-50-
monophosphate dehydrogenase 1 and 2 (IMPDH1, IMPDH2),
which maintain the intracellular balance of A and G nucleotides
and thus play a key role in cell proliferation. Consequently, the
stability changes of other proteins so far not implicated in the
cell cycle should be indicative of their cell-cycle-related roles,
as will be discussed and shown below.
Protein Abundance and Stability Independently Vary
from Each Other during the Cell Cycle
Overall, we uncovered significant cell-cycle-dependent changes
in stability and abundance for 1,592 and 1,044 unique proteins,
respectively (Figure 2C; Table S2). Most abundance changes
occurred in early G1, whereas most stability changes occurred
in mitosis.
We used gene ontology (GO) analysis to obtain an overview of
which cellular processes and substructures are most promi-
nently affected by cell-cycle-dependent changes in stability.
We identified various processes related to the cell cycle (Fig-
ure 2D; Table S5), such as nuclear envelope breakdown and
the purine salvage pathway. During mitosis, we observed stabi-
lization of signaling-, DNA-, and chromatin-associated proteins
and destabilization of proteins involved in metabolic processes.
The subcellular distribution of proteins displaying altered stability
was relatively even (Figure S2A); however, the endoplasmic re-
ticulum contained more proteins with variable stability (p value
3.04 3 105, Fisher’s exact test) (Figures S2A and S2B). ThisFigure 2. Abundance and Stability Changes of Cell-Cycle Markers, Pat
(A) Calculated abundance and stability scores for CCNA and CDK1 in a circular pl
shown in the paper represent three independent biological replicates. *p < 0.05,
(B) Cell-cycle-dependent changes in protein stability of AHCYL1, RECQL, IMPD
(C) Number of significantly affected proteins in either stability (purple) or abunda
(D) Pathways from the Reactome Pathway Database indicate howmany proteins a
of proteins affected in the pathway in at least one cell-cycle stage is correlated wi
pathway components that significantly change in their stability. If the circle is fully
then proteins were quantified but did not change in their stability in the respectiv
(E) Clustering stability and abundance of significantly changing proteins results in
gov/) with all quantified proteins as a background. The top result (lowest FDR) for
cluster for which the FDR < 0.05 and linked to the heatmap.
(F) Violin plots with the indicated median and interquartile range comparing pr
significantly in abundance or stability compared with non-changing proteins. Sig
*p < 0.05, **p < 0.01, and ***p < 0.001.
(G) 2D density plot of protein half-lives comparison with protein melting points in
See also Figures S1 and S2 and Tables S2, S3, S4, and S5.
1498 Cell 173, 1495–1507, May 31, 2018might reflect the morphological changes in the endoplasmic re-
ticulum during mitosis (Schwarz and Blower, 2016).
To explore a potential relationship between stability and
abundance, we clustered the combined abundance and stability
scores based on their Euclidean distance (Figure 2E; Table S2).
The resultant 21 distinct clusters primarily consisted of proteins
affected in either their stability or their abundance (Figures 2E
and S2C), strongly suggesting that these proteomic traits are
controlled independently. Comparison of our relatively quanti-
fied data with previously determined protein half-lives (Boisvert
et al., 2012) revealed that proteins changing in abundance
across the cell cycle turn over significantly faster (Figure 2F). In
contrast, proteins changing in stability tend to have longer half-
lives, but with a smaller effect size (Figure 2F). Further, protein
melting points were not correlated with protein half-lives (Fig-
ure 2G). We conclude that the cell-cycle-dependent variance
of stability is controlled through mechanisms that do not affect
protein abundance.
Stability Changes Reveal Cell-Cycle Functions for
Enzymes
Cell-cycle progression is tightly coupled to intracellular meta-
bolism (Lee and Finkel, 2013). However, it has been challenging
to identify metabolic enzymes that are more active because of
increased substrate availability, rather than increased enzyme
abundance. Since substrate binding increases the stability of en-
zymes (Savitski et al., 2014), our data can serve as a proxy for
enzyme activity. Indeed, the variation of enzyme stability coin-
cided with cell-cycle progression for several interconnected
metabolic pathways (Figure 3A; Table S5). The fatty acid biosyn-
thesis pathway is required for mitotic exit (Scaglia et al., 2014),
and its key enzymes were stabilized in mitosis and early G1.
The non-oxidative branch of the pentose phosphate pathway
(PPP) has an increased metabolic flux at G1/S (Fridman et al.,
2013) that is reflected in the higher stability of the respective
enzymes. This provides evidence for cell-cycle-dependent
changes in the non-oxidative branch of the PPP not only on
the metabolic but also on the proteome level.
Furthermore, we depleted three metabolic enzymes with
cell-cycle-dependent stability patterns: catechol-O-methyl-
transferase (COMT), cystathionine beta-synthase (CBS), andhways, and Cell Functions
ot. The outer circle represents stability and the inner circle abundance. All data
**p < 0.01, and ***p < 0.001, unless otherwise indicated.
H1, and IMPDH2.
nce (orange).
re associated with the pathway in general (number in brackets); the percentage
th the size of the circle. The color of the circle indicates the mean stability of the
opaque, the adjusted combined p value is < 0.05; if the bubble is transparent,
e cell-cycle stage. Pathways are categorized into broader functional groups.
21 individual clusters that were analyzed using DAVID (https://david-d.ncifcrf.
all functional categories (colored as indicated in the legend) is shown for each
otein half-life (from Boisvert et al. [2012]) distributions of proteins changing
nificance levels obtained from a Wilcoxon signed-rank test were encoded as
G1/S phase fitted by a linear model.
Figure 3. Metabolic Pathways
Cell-cycle effect on the stability of protein com-
ponents of the pentose phosphate pathway (PPP).
On the left-hand side, the PPP is shown along with
related pathways colored by average stability
across the stages from early S to S/G2. On the
right-hand side, the same constellation is shown. It
is colored in stability values derived from mitosis
(left) and G1 phase (right) for each protein. TKT and
TALDO1 are two enzymes of the PPP that become
significantly destabilized upon the onset ofmitosis.
See also Figure S3 and Table S2.choline-phosphate cytidylyltransferase A, (PCYT1A). Doing so
significantly reduced both the frequency of cells in S phase
and proliferation (Figures S3A–3F).
In summary, our data not only recapitulate the importance of
previously characterized enzymes contributing to cell-cycle pro-
gression but they also can be mined to identify the time-resolved
metabolic activity of enzymes.
RNA Polymerase II Stability Correlates with
Transcriptional Activity
Next, we investigated whether our data capture changes in pro-
tein-chromatin interactions. We found that RNA polymerase II
(Pol II) subunits POLR2A and POLR2B were significantly
decreased in both abundance and stability in mitosis (Figure 4A).
The melting profiles of POLR2A and POLR2B displayed biphasic
behaviors in interphase cells, but were monophasic in mitosis
(Figure 4B; Table S4), suggesting the existence of two distinct
populations of RNA Pol II subunits in interphase.
Transcriptional arrest occurs in mitosis, and it has been re-
ported that RNA Pol II is cleared from chromatin (Liang et al.,
2015). We hypothesized that the distinct RNA Pol II populations
in interphase reflect a transcriptionally inactive subpopulation
not bound to DNA and a more stable, transcriptionally active
subpopulation bound to DNA. To test this, we treated asynchro-
nous cells with the bromodomain inhibitor JQ1, which causes
transcription elongation defects (Love´n et al., 2013). JQ1 treat-
ment led to reduced RNA Pol II stability (Figures 4C and S4A)
and a slight increase in abundance (Figure 4D), suggesting that
RNA Pol II stability correlates with transcriptional activity.
The phosphorylation state of the POLR2A carboxy-terminal
domain (CTD) changes at different stages of transcription,
although both phosphorylated and unphosphorylated forms
occur in the subpopulation that is not bound to DNA (Komarnit-
sky et al., 2000). To rule out that the change in POLR2A stability is
solely due to a change in phosphorylation state, we used a phos-
pho-specific antibody to monitor POLR2A stability. JQ1 treat-
ment destabilized phosphorylated POLR2A (Figures S4C and
S4D), indicating that the reduced stability was not driven by
dephosphorylation. We also treated HeLa cells with THZ1, a
CDK7 inhibitor that has been reported to reduce RNA Pol IIoccupancy at promoters and gene bodies
(Kwiatkowski et al., 2014). THZ1 treat-
ment led to reduced POLR2A stability
(Figures 4C and S4B) and reducedPOLR2A levels (Figure 4D), both of which likely contribute to
the potent transcriptional arrest observed with this inhibitor
(Kwiatkowski et al., 2014).
To confirm that DNA-binding stabilizes RNA Pol II, we per-
formed thermal shift experiments on purified yeast RNA Pol II
in the presence of DNA. Consistent with the above observations,
the addition of DNA stabilized RNA Pol II (Figures 4E and S4E).
These findings suggest that the decreased stability in mitosis
compared to interphase is due to the clearance of a subpopula-
tion of RNA Pol II from chromatin and coincides with a downre-
gulation of the overall RNA Pol II levels. In general, our results
suggest that the measurement of RNA Pol II stability in situ cor-
relates with the transcriptional activity in cells.
Complex-Dependent Variation in Stability across the
Cell Cycle
We calculated the correlation of the abundance and stability
values of proteins that are subunits of the same annotated com-
plex (Ori et al., 2016) and compared the resultant distribution to
correlation values stemming from all other proteins that are not
part of annotated complexes (Figure 5A). The abundance pro-
files of protein complex subunits across the cell cycle were
highly correlated (Figure 5B), even stronger correlation was
observed for stability (Figure 5C), suggesting that protein com-
plexes mostly melt as a whole unit in situ once a critical temper-
ature is reached. Indeed, protein complex subunits have a signif-
icant tendency toward coherent melting behavior (Figure S5A).
Combined stability and abundance values yielded the best
discrimination between proteins that are part of complexes
from those that are not, including complexes with temporally
regulated assembly (Jensen et al., 2006) (Figures 5D and S5B).
We found that subunit correlation patterns are indicative of
stable subcomplexes, or of subunits that are loosely associated
or potentially moonlight in other complexes. For example, in the
exosome complex (Figure S5C) the core components displayed
a high degree of correlation, while the two catalytic subunits,
DIS3 and EXOSC10, did not follow this pattern. While the core
subunits were collectively destabilized in mitosis, DIS3 and
EXOSC10, which are uniquely required for mitotic progression
in fission yeast (Murakami et al., 2007) and Drosophila (GrahamCell 173, 1495–1507, May 31, 2018 1499
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RNA Polymerase II in Mitosis
(A) Circle and line plots for two subunits of RNA Pol
II (POLR2A and POLR2B) show the significant
change in stability (purple) and abundance (NP-40,
orange, SDS green).
(B) Melting curves (generated in TPP-TR experi-
ments) for POLR2A and POLR2B show the biphasic
melting behavior in G1/S, compared with mitosis.
(C) TPP-TR experiment of HeLa cells treated
with vehicle (DMSO), BET inhibitor JQ1, or CDK7
inhibitor THZ1. Quantified western blot data for
POLR2A. SEM is shown.
(D) Quantification of POLR2A protein level after a
3-hr treatment with DMSO, JQ1, or THZ1 (western
blot quantification). SEM is shown.
(E) Stabilization of purified RNA Pol II complex from
yeast by its specific DNA sequence. The stabiliza-
tion was calculated as a fold change against the
control (without DNA) for each temperature. Coo-
massie gel quantification.
See also Figure S4 and Tables S2, S3, and S4.et al., 2009), displayed increased stability in mitosis. Likewise,
the 26S proteasome, a complex linked to cell-cycle progression
(Guo et al., 2016), showed a different stability and abundance
variation in a subset of proteins belonging to the 19S regulatory
subcomplex (Figure S5D). Furthermore, we observe that the core
SMC subunits of condensin II have a distinct behavior from the
rest of the complex (Figure S5E).
Also in case of the nuclear pore complex (NPC), the combined
nucleoporin (Nup) stability and abundance profiles clustered into
known subcomplexes (Figures 5E and 5F). The NPC has a cell-
cycle-dependent assembly status: it ismembrane bound in inter-1500 Cell 173, 1495–1507, May 31, 2018phase but resolves into soluble sub-
complexes during mitosis, as triggered
by phosphorylation (Laurell et al., 2011).
Surprisingly, the stability behavior of the
distinct subcomplexes was strikingly
different, even with opposite sign. Major
scaffolding subcomplexes showed a mi-
nor destabilization in mitosis, indeed mir-
roring theNPCassembly status. The effect
sizes for the Y and inner ring complexes
are slightly different, possibly reflecting
architectural disparities that impact on
their extractability (Figures 5F and S5F).
In strikingcontrast,most intrinsically disor-
dered Nups, such as NUP358 (RANBP2),
remained stable in mitosis or were even
strongly stabilized. This is unexpected,
becausemany of the Nupswith high intrin-
sically disordered protein (IDP) content are
aggregation prone proteins (Lemke, 2016).
Disordered Proteins Are Stabilized
during Mitosis
NUP358 critically contributes to Y com-
plex oligomerization in intact NPCs duringinterphase (von Appen et al., 2015). In mitosis, however, it disso-
ciates from the Y complex and localizes to the spindle region
(Joseph et al., 2004), and depletion of NUP358 leads to spindle
defects (Hashizume et al., 2013). NUP358 is a large, multifunc-
tional protein that contains several folded domains linked by
long, intrinsically disordered regions that are important for nucle-
ocytoplasmic exchange in interphase.
Similarly to NUP358 (Figure 6A), several other confirmed spin-
dle binding proteins displayed strong mitotic stabilization, such
as CHD4 (Yokoyama et al., 2013), KIF4A (Kurasawa et al.,
2004), and SMARCA4 (Yokoyama et al., 2009) (Figures 6B,
A B
D
F
E
C Figure 5. Co-stability of Known Protein
Complexes and Submodules of the NPC
(A) Schematic illustration of correlation analysis
(see STAR Methods for further details).
(B–D) Density graph of correlation coefficient values
(Pearson) calculated from abundance (B), stability
(C), and concatenated abundance-stability (D)
profiles between proteins known to be members of
the same complex (green). The gray density shows
correlation values from all combinations of proteins
not associated with any complex.
(E) Density graph of correlation values (Pearson)
calculated from concatenated abundance-sta-
bility profiles of all subunits of the nuclear pore
complex (NPC).
(F) Correlation matrix of NPC subunits based on
their concatenated abundance-stability profiles.
The colors on the left indicate their association with
a specific substructure of the NPC, as colored in the
respective cartoon. The scale on the bottom of the
matrix indicates how many mitotic phosphorylation
sites the corresponding protein subunit contains as
described by Olsen et al. (2010).
See also Figure S5 and Table S2.S6A, and S6B). Compared to the entire proteome, annotated
mitotic spindle binding proteins (Sauer et al., 2005) had a
significantly lower stability (Figure S6C; Table S6). Since the
aggregation of several of these proteins in mitosis was already
substantial at 47C (30% on average as in the case of
NUP358) (Figure 6A), one would expect this to have a cata-
strophic effect on the spindle integrity. Indeed, heating mitotic
cells to 47C resulted in a severely damaged mitotic spindle,
and at 50C no traces of the spindle were detectable (Figure 6C).
We further examined proteins that were stabilized in mitosis
and found common functional and biophysical characteristics:
such proteins were significantly enriched (false discovery rate
[FDR] < 5%) for the GO terms, DNA binding, chromosome and
chromatin organization, and transcription-related processes
(Figures S6D and S6E; Table S5). Systematic computational par-
titioning of proteins according to the fraction of their sequence
predicted as disordered (Oates et al., 2013) revealed that themitotic stabilization behavior is specific
to proteins with large proportions of disor-
dered regions (Figure 6D).
The synchronized stability change of the
disordered proteins during mitosis sug-
gests the presence of a regulatory switch.
We considered mitotic phosphorylation,
given that it is known to occur in disor-
dered regions (Tyanova et al., 2013), and
that phosphorylation-mediated folding of
disordered proteins has been reported
(Bah et al., 2015). We found that proteins
with annotated mitotic phosphorylation
sites (Olsen et al., 2010) (Table S6) were
stabilized in mitosis, and that there is a
considerable overlap of disordered and
mitotically phosphorylated proteins thatexhibit the strongest stabilization (Figures 6E and 6F). A similar
trend is observed for sumoylation, a modification linked to cell-
cycle progression andmitosis (Pelisch et al., 2014) and crosstalk
with phosphorylation (Yao et al., 2011) (Figure S6F). The trend is
not observed when non-mitotic phosphorylation or ubiquitina-
tion, acetylation or methylation sites are considered (Figure S6F)
(Hornbeck et al., 2015).
Taken together we observe that chromatin and spindle related
proteins with low stability and disordered regions are stabilized
in mitosis. This effect is most pronounced for proteins that
contain annotated mitotic phosphorylation sites.
Solubility Changes Capture Cell-Cycle-Dependent
Phase Transitions
The control measurements of protein abundance in mild and
strong detergent that we had originally introduced to disentangle
protein expression from solubility, indicated striking solubilityCell 173, 1495–1507, May 31, 2018 1501
Figure 6. Disordered, Mitotically Phosphor-
ylated Proteins Are Stabilized duringMitosis
(A) Melting curves of NUP358 in G1/S and mitosis.
Data represent three biological replicates.
(B) Scatterplot comparing the melting tempera-
tures (Tm) for proteins inG1/S (x axis) andM (y axis).
A shift toward higher melting points in mitosis for
representative proteins CHD4, KIF4A, NUP358,
and SMARCA4 are indicated with coloring.
(C) Microscopy images of the mitotic spindle at
different temperatures. Mitotic HeLa Kyoto EGFP-
alpha-tubulin/H2B-mCherry cells were imaged
after heat treatment. z stacks maximum intensity
projections of samples treated at the indicated
temperatures are shown. On the merged images,
a-tubulin and H2B are shown in magenta and
cyan, respectively.
(D) Scatterplots illustrate the melting point shift
observed from G1/S (x axis) to M (y axis) at
different cutoffs for the relative coverage of
disordered regions (indicated above each plot as a
percentage).
(E) Shift of melting point for proteins containing
mitotically regulated phosphorylation sites as
described in Olsen et al. (2010).
(F) Melting point difference for proteins with
different levels of disordered regions in their
sequence and containing mitotic phosphorylation
sites. SEM is shown.
See also Figure S6 and Tables S4 and S6.transitions in well-defined subproteomes at specific cell-cycle
stages. For example, ribosomal proteins, nuclear lamins, vimen-
tin and plectin, all displayed a strong transition from a non-
soluble to soluble state in mitosis (clusters 19, 20, and 21; Fig-
ures 2E, 7A, and S2). This observation reflects known properties
of cellular substructures: nuclear lamins and vimentin are both
phosphorylated, leading to depolymerization of filaments in
mitosis, and plectin undergoes a phosphorylation-triggered tran-
sition from an insoluble to soluble state (Chou et al., 1990; Fois-
ner et al., 1996). Strikingly, the nuclear lamins showed a delay in
the transition back to the insoluble state in early G1 (Figures 7A
and 7B).1502 Cell 173, 1495–1507, May 31, 2018Further, we observed that such solu-
bility transitions captured components of
phase-separated, membraneless organ-
elles that are dissolved in mitosis. For
instance, various nucleolar proteins are
more soluble in mitosis when the nucle-
olus is dissolved (Hernandez-Verdun,
2011) (Figure 7A). Our above-described
data capture such transitions only if they
occur during the cell cycle, but they are
not suitable to quantify the fractions of
a protein in the soluble and insoluble
state. Therefore, we quantified proteome
solubility under mild and strong deter-
gent conditions for the G1/S stage as
compared to mitosis in a dedicated TMT
experiment (Figure S7A; Table S7).The analysis revealed that a small chromatin-associated frac-
tion of the proteome is consistently insoluble in G1/S and
mitosis. This fraction includes CDCA8, INCENP, and AURKB,
which are core members of the chromosomal passenger com-
plex (Figure S7A) and key regulators of several mitotic events
(Carmena et al., 2012), and SUPT16H and SSRP1 of the FACT
complex, which is essential for microtubule growth and bundling
inmitosis (Zeng et al., 2010) (Table S7). We did not observe a sin-
gle protein becoming more than 2-fold less soluble in mitosis
compared to G1/S (Table S7), indicating that there is no pro-
nounced transition from a soluble to insoluble state upon mitotic
entry. In striking contrast, various proteins became significantly
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Figure 7. Solubility Transitioning Proteome
(A) Abundance (measured in NP-40 lysis buffer in orange and SDS lysis buffer in green) and stability (purple) profiles of three protein groups (nucleolar, ribosomal,
or lamins and others from cluster 19, 20, or 21 as shown in Figure 2E, respectively) are shown across all cell-cycle stages.
(B) Scatterplot depicting the abundance scores in SDS lysis (y axis) versus abundance scores from NP-40 lysis (x axis) for each protein. The indicated functional
groups are solubilized during mitosis, but not in G1, except for lamins, which also remain soluble during G1 phase.
(C) Boxplots of relative coverage of disordered regions for proteins significantly changing in solubility in mitosis versus G1/S compared to other proteins.
Comparisons are made for all proteins, as well as for proteins located within different membraneless organelles as defined by the Human Protein Atlas (HPA).
(D) Solubility differences in mitosis versus G1/S for proteins with different levels of disordered regions in their sequence and containing mitotic phosphorylation
sites. SEM is shown.
(E) Percentage of the proteomes of different organelles significantly changing in solubility inmitosis versusG1/S and localization as defined byHPA, except for the
nuclear envelope, which combines nuclear membrane annotated proteins as defined by HPA and proteins annotated as inner nuclear membrane proteins by
Wilkie et al. (2011).
(legend continued on next page)
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more soluble in mitosis. Similarly, but not identical, to the mitot-
ically stabilized IDP proteome discussed above, those proteins
were strongly enriched in RNA binding functions (Figure S7B),
mitotic phosphorylation sites (Olsen et al., 2010) (Figures 7C
and 7D; Table S6) and sumoylation (Figure S7C). Many of them
were components of the nuclear envelope (Thul et al., 2017;
Wilkie et al., 2011) and also membraneless organelles (Thul
et al., 2017).
The proteins identified to undergo a solubility transition in
mitosis comprise only a fraction of the previously annotated pro-
teomesof thesemembraneless organelles (Thul et al., 2017), indi-
cating that their core proteomemight be less extensive than pre-
viously thought (Figures 7E and 7F). However, the subproteomes
that did undergo a solubility transition were strongly enriched in
disordered regions (Figure 7C) and captured key phase sepa-
rating proteins of membraneless organelles. Among those were
proteins with reported roles for nucleolar morphology, such as
nucleostemin, GNL3 (Romanova et al., 2009), fibrillarin, FBL
(Tiku et al., 2016), nucleolar protein 7, NOL7 (Kinor and Shav-
Tal, 2011), and the protein SON, one of the most strongly transi-
tioningproteins in nuclear speckles and recently proposed tobea
key scaffolding factor for these membraneless organelles
(Sharma et al., 2010) (Figure 7F). An exception to this trend was
the transcription factor 1, UBTF (Figures 7F and S7A), which
acts as a molecular beacon to recruit additional proteins during
the de novo biogenesis of the nucleolus (Grob et al., 2014). Our
data show that UBTF has a very rare behavior among the nucle-
olar proteins, in that it remains insoluble during mitosis.
The nucleolus is the site for ribosome assembly (Kressler et al.,
2010). When it dissolves in mitosis, non and partially assembled
ribosomal proteins are set free and their exact fate remains
understudied. The stability of many ribosomal proteins was
significantly decreased in mitosis (Figure 7A). A subpopulation
of ribosomal proteins that is insoluble in G1/S becomes soluble
in mitosis (Figure 7F) and might be attributed to non-assembled
species. In line with this view, the insoluble interphase subpopu-
lations of the 40S and 60S components have significantly
different effect sizes (Figures 7F and 7G), reflecting the shorter
residence time of 40S proteins in the nucleoulus as compared
to 60S proteins (Lam et al., 2007). The ribosomal associated
complex that participates in maturation of the large 60S ribo-
somal subunit, as determined by Havugimana et al. (2012)
(BOP1, RRS1, GNL3, EBNA1BP2, FTSJ3, and MKI67), exhibited
the largest effect size in its coherent solubility transition (Figures
7F and 7G), indicative of a predominant nucleolar localization in
G1/S.
Taken together, our data delineate the insoluble and the cell-
cycle-dependent, solubility transitioning proteome. Our experi-
mental strategy enables unbiased assessment of key phase(F) Scatterplots comparing the solubility of proteins in G1/S and the relative cha
cytoplasmic ribosomal subunits, and the ribosome-associated complex determ
MKI67). Proteins with negative x axis values and close to zero y axis values are i
values and positive y axis values are insoluble in G1/S and become more soluble
G1/S are marked in red.
(G) Solubility differences in mitosis versus G1/S compared between proteins
associated complex determined by Havugimana et al. (2012).
See also Figure S7 and Tables S3 and S7.
1504 Cell 173, 1495–1507, May 31, 2018transitioning proteins responsible for the altered solubility state
of the mitotic cell and provides molecular insight into the mitosis
specific morphological changes.
DISCUSSION
We have performed an in-depth, proteome-wide stability
profiling of the eukaryotic cell cycle. We discovered pervasive
protein thermal stability variation during the cell cycle, represent-
ing a substantial layer of proteome organization that is on par
with the variability of protein abundance.
Our results with RNA Pol II suggest that relative changes in
transcriptional activity can be assessed in situ by measuring
the stability of POLR2A. The disappearance of the more stable
POLR2A population during mitosis coincides with the overall
reduction of POLR2A levels. A speculative interpretation could
be that the stable DNA-bound RNA Pol II fraction is specifically
degraded upon mitotic entry.
The combined stability and abundance variation of NPC and
other complexes across the cell cycle serves in delineatingmajor
subcomplexes and moonlighting subunits. This highlights the
utility of the present dataset for structural biologists, as it can
be used for hypothesis generation of cell-cycle-dependent com-
plex composition and subunit function.
Mitotically phosphorylated IDPs are stabilized in mitosis. The
NPC illustrates the significance of this finding. Although intrinsi-
cally disordered Nups are notoriously aggregation prone, scaf-
fold Nups provide a grafting surface that restrains their local con-
centration in interphase (Lemke, 2016; Milles et al., 2013). NPC
disassembly, however, does not render intrinsically disordered
Nups aggregation prone. Strikingly, NUP358 that facilitates scaf-
fold Nup oligomerization in interphase (von Appen et al., 2015) is
stabilized in mitosis. These insights exemplify the challenge that
cells have to deal with during the morphological changes occur-
ring in mitosis and apparently address by major transitions in
their biophysical environment. It is possible that IDPs are inte-
grated in specific protein complexes or subcellular structures
in interphase that restrain their local concentration, such is the
case, for instance, for NUP358 and the NPC scaffold. In mitosis,
these restraints on local concentration could potentially disap-
pear and render IDPs aggregation prone. Phosphorylation of
these proteins might be important to prevent aggregation in
mitosis. Their similar biophysical milieu might phase separate
them into the spindle region, where they are less exposed to ag-
gregation triggers, such as membranes (Jiang et al., 2015).
We also mapped the subset of the proteome undergoing sol-
ubility transitions, from an insoluble to a soluble state as well as
the proteins that are permanently insoluble, during the cell cycle.
The molecular signature of RNA binding enriched proteins thatnge in solubility of proteins in mitosis versus G1/S for different organelles, the
ined by Havugimana et al. (2012) (BOP1, RRS1, GNL3, EBNA1BP2, FTSJ3,
nsoluble in G1/S and remain insoluble in mitosis. Proteins with negative x axis
in mitosis. Proteins that are significantly more soluble in mitosis compared to
from the small and large cytoplasmic ribosomal subunits and the ribosome
are solubilized in mitosis is very similar to the DNA binding
enriched subproteome that gets stabilized in mitosis. The two
subproteomes have an overlap of 15%and are enriched in disor-
dered regions and mitotic phosphorylation. The solubility transi-
tion of the cell in mitosis is often obvious on a morphological
scale, e.g., the dissolution of the nucleolus is apparent by light
microscopy. Our data categorize the proteins involved in this
process, several of which play key roles in the architecture of
membraneless organelles. The vast majority of all proteins that
are insoluble during interphase are solubilized in mitosis. We
conclude that the mitotic cell is more soluble and less aggrega-
tion prone as compared to the interphase cell.
In conclusion, our study reveals that the biophysical properties
of proteins extensively vary across the cell cycle, reflecting
changes in metabolic activity, complex composition, and tran-
scriptional activity. It can thus be argued that changes in stability
represent a robust way to identify proteins whose activity and
interaction patterns vary across the cell cycle. In contrast,
changes in abundance will typically not reflect such variations.
We show the utility of our dataset for biological hypothesis gener-
ation and expect it to becomewidely used inmetabolomics, tran-
scription, structural biology, IDPs, and cell-cycle-related studies.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture and cell cycle arrest
HeLa Kyoto cells (female) were cultured at 37C, 5% CO2, in DMEM including 1mg/ml glucose, supplemented with 10% FBS, 1mM
glutamine. Cells were synchronized in G1-S by a double thymidine block (addition of 2mM thymidine (Calbiochem, #6060) overnight,
release cells for 8 hours, second block with 2mM thymidine overnight). After the second release cells were collected at four different
time points: 0 hours (G1-S phase), 2 hours (early S phase), 4 hours (late S phase), and 6 hours (S-G2 phase). For synchronization in
mitosis cells were treated overnight with 2mM thymidine, released for 4 hours and treated with 100 ng/ml nocodazole (Millipore,
#487928) overnight. After 0.5 hour release cells were collected (M phase). For synchronizing cells in G1, 100 ng/ml nocodazole
was added overnight, then mitotic cells were collected by shake-off and released into fresh medium, letting them grow for 4.5 hours,
when only attached cells were collected. Also, an asynchronous culture was used as a control.
The arrest was assessed by flow cytometry, and at the same time thermal proteome profiling experiments were performed. An
aliquot of the cells was kept to perform a SDS-lysis to determine protein expression changes. All experiments were done in biological
triplicates.
METHOD DETAILS
Flow cytometry
Cell cycle analysis was performed by flow cytometry with two bivariate analyses: DNA/ Proliferating Cell Nuclear Antigen (PCNA) and
DNA/ phosphorylated Serine 10 of histone H3 (pH3)
PCNA staining was adapted from Sasaki et al. (1993). 1x106 cells were permeabilized for 10 min on ice with 0.1% Triton X-100/1%
bovine serum albumin (BSA)/PBS, and then fixed with methanol at 20C for 3 min. After pelleting, cells were resuspended and
stored in PBS at 4C. For pH3 staining, 2x106 cells were fixed with 1% formaldehyde for 15 min at RT. Cells were then resuspended
in PBS and stored in 70% ethanol at 4C.
Both samples were spun and the cell pellet was resuspended and incubated for 15 min in PBS at room temperature before
continuing with blocking in 1% BSA in PBS for 10 min. Cells were then incubated with primary antibodies (anti-PCNA PC10 conju-
gated with Alexa Fluor 488, Cell Signaling Technology #8580 or anti-Phospho-Histone H3 (Ser10) conjugated with Alexa Fluor 647,
Cell Signaling Technology #9716S) for 1 hour at room temperature. Cells were washed and DNA was stained by addition of 20 mg/ml
propidium iodide (PI) in 0.1% Triton X-100 containing 0.2 mg/ml RNase.
Samples were analyzed on a BD LSR Fortessa instrument. For PI detection, the laser line of 561 nm and 75 mV with a band pass
(BP) filter of 610/20nmwas used. Alexa Flour 488was detectedwith a laser line of 488 nm, 50mW, and a BP 530/30 nm. In the case ofCell 173, 1495–1507.e1–e6, May 31, 2018 e2
Alexa Fluor 647, a laser line of 640 nm, 80 mV and BP 670/14 was used. Cell cycle stage analysis was performed with FlowJo v10
software. Bivariate analysis of PCNA versus DNA content presented an inverted U shape; cells with the higher signal were considered
to be in S-phase. Cells with a G2/M DNA content, and positive for pH3 antibody were considered mitotic. The % of cells in G1 was
calculated by fitting the PI signal to a cell cycle distribution using the Watson pragmatic model approach.
Thermal protein profiling and sample preparation for MS
Thermal protein profiling was done as previously described (Becher et al., 2016). In brief, cells were harvested, washed with PBS and
10 aliquots, each of 0.53 106 cells, were distributed in PCR tubes. Each aliquot was heated for three minutes to a different temper-
ature (37.0-40.4-44.0-46.9-49.8-52.9-55.5-58.6-62.0-66.3C). Lysis buffer (final concentration 0.8%NP-40, 1.5mMMgCl2, protease
inhibitor, phosphatase inhibitor, 0.4 U/ml benzonase) was added and cells were incubated at 4C for one hour. Protein aggregates
were removed. From the soluble fraction the protein concentration was determined and for sample preparation 10 mg protein (based
on two lowest temperatures) were taken further. Proteins were reduced, alkylated and digested with trypsin/Lys-C with the SP3 pro-
tocol (Hughes et al., 2014). Peptides were labeled with TMT10plex (Thermo, #90110). Here, samples were combined in two ways:
either all temperatures of one cell cycle arrest were combined allowing the determination of melting curves, or all cell cycle arrests
were combined for each temperature resulting in seven conditions analyzed together. Pooled samples were fractionated on a
reversed phase C18 system running under high pH conditions, resulting in twelve fractions (Hughes et al., 2014). In addition, both
samples from NP-40 lysis (37C) and SDS lysis from G1/S or M arrested samples were combined, allowing the determination of
protein solubility differences.
LC-MS/MS measurement
Peptides were separated using an UltiMate 3000 RSLC nano LC system (Thermo Fisher Scientific) equippedwith a trapping cartridge
(Precolumn C18 PepMap 100, 5mm, 300 mm i.d. x 5 mm, 100 A˚) and an analytical column (Acclaim PepMap 100, 75 mm x 50 cm C18,
3 mm, 100 A˚). The LC system was directly coupled to a Q Exactive Plus mass spectrometer (Thermo Fisher Scientific) using a Nano-
spray-Flex ion source. Solvent A was 99.9% LC-MS grade water (Fisher Scientific) with 0.1% formic acid and solvent ‘‘B’’ was 99.9%
LC-MS grade acetonitrile (Fisher Scientific) with 0.1% formic acid. Peptides were loaded onto the trapping cartridge using a flow of
30 mL/min of solvent A for 3 min. Peptide elution was afterward performed with a constant flow of 0.3 mL/min using a total gradient
time of 120min. During the elution step, the percentage of solvent B was increased stepwise: 2% to 4%B in 4min, from 4% to 8% in
2 min, 8% to 28% in 96 min, and from 28% to 40% in another 10 min. A column cleaning step using 80% B for 3 min was applied
before the system was set again to its initial conditions (2% B) for re-equilibration for 10 minutes.
The peptides were introduced into the mass spectrometer Q Exactive Plus (Thermo Fisher Scientific) via a Pico-Tip Emitter 360 mm
OD x 20 mm ID; 10 mm tip (NewObjective). A spray voltage of 2.3 kV was applied and themass spectrometer was operated in positive
ion mode. The capillary temperature was 320C. Full scan MS spectra with a mass range of 375-1200 m/z were acquired in profile
mode in the Orbitrap using a resolution of 70,000. The filling time was maximum 250 ms and/or a maximum of 3e6 ions (automatic
gain control, AGC) was collected. The instrument was cycling between MS and MS/MS acquisition in a data-dependent mode and
consecutively fragmenting the Top 10 peaks of the MS scan. MS/MS spectra were acquired in profile mode in the Orbitrap with a
resolution of 35,000, a maximum fill time of 120 ms and an AGC target of 2e5 ions. The quadrupole isolation window was set to
1.0 m/z and the first mass was fixed to 100 m/z. Normalized collision energy was 32 and the minimum AGC trigger was 2e2 ions
(intensity threshold 1e3). Dynamic exclusion was applied and set to 30 s. The peptide match algorithm was set to ‘preferred’ and
charge states ‘unassigned’, 1, 5 - 8 were excluded.
RNAi experiments
For knockdown experiments HeLa Kyoto cells were transiently transfected using siRNA spotted cell culture plates and CELLviewTM
slides following a previously described (Erfle et al., 2007) reverse transfection protocol using pre-designed Silencer Select siRNAs
(Ambion). In brief, the transfection solution composed of 20 ml siRNA (3 mM), 7 ml Lipofectamine 2000 (Invitrogen), 12 ml Opti-MEM
(Invitrogen) containing 0.4 M sucrose, and 12 ml water was prepared. After incubation for 20 min at room temperature, 29 ml of 0.2%
gelatin and 3.5x10%–4% fibronectin were added. Finally, the transfection cocktail was diluted 1:50 and 300 ml were spotted on
24-well cell culture plates, or 50 ml on CELLviewTM slides respectively, followed by immediate lyophilization using the concentrator
miVAC (Genevac). Dependent on the incubation time, 12500 (2d), 6250 (3d) or 3125 (4d) cells/well were seeded on the spotted
24-well plates.Additionally, anon-transfectedcontrol (NTC)was included foreachexperiment,wherecellswereseededonnon-spotted
wells. The knockdown of target geneswas validated on the level ofmRNA by quantitative real-time PCR (qRT-PCR) analysis after 2d of
transfection, aswell as on the level of protein by LC-MS/MSanalysis after 2, 3 and 4d of transfection (MSanalysis as described before).
For qRT-PCR analysis, mRNA extraction was performed using the RNeasy Mini Kit (QIAGEN) according to the manufacturer’s in-
structions and including an on-column DNase I digestion. Subsequently, 700 ng total RNA were converted into cDNA using the
SuperScriptTM III Reverse Transcriptase (Invitrogen) following the manual for first-strand cDNA synthesis. qRT-PCR reactions
were performed on a StepOnePlus Real-Time PCR System (Applied Biosystems) using 5 ng cDNA, 0.2 mM gene-specific primers
and 1x Power SYBR Green PCR Master Mix (Life Technologies). For each condition technical triplicates were prepared and the
mean threshold cycle (CT) calculated. For normalization, ACTB levels were used as an internal reference and mRNA levels relative
to siCTRL were calculated according to the 2-DDCt method.e3 Cell 173, 1495–1507.e1–e6, May 31, 2018
Target gene Silencer Select siRNA ID (Ambion) Primer (50 to 30)
COMT s39 For: GCGACAAGAAAGGCAAGATCG
Rev: TCCTTCACGCCAGCGAAAT
CBS s290 For: GGGTCCCCAGAGGATAAGGAA
Rev: ATTTTTGGAGATTTTGCCGGGG
PCYT1A S10166 For: ATGAGGTGGTGAGGAATGCG
Rev: AACATGCCTGCCTCCTTGAT
siCTRL (XWNEG9) S444246 -Cell cycle analysis was performed by flow cytometry using PI staining. After 4d of transfection cells were harvested, washed and
fixed in 66%Ethanol at 4C for several hours. After washing, DNAwas stainedwith PI and the cell cycle analyzed as described above.
In addition, apoptosis was measured using the Annexin V-FITC Detection kit (Promokine) according to the manual.
For assessment of live and dead cells a commercial assay was used (Promega, MultiTox-Fluor Multiplex Cytotoxicity Assay) and
the manufacturer’s protocol was followed.
CETSA with two inhibitors
HeLa Kyoto cells were treated with either 5 mM JQ1 (Sigma Aldrich), 5 mM THZ1 (Cayman chemicals) or DMSO (vehicle) for 3 h at
37C, 5% CO2, in DMEM supplemented with 2% FBS and 1mM glutamine. Heat treatment, lysis and removal of aggregates were
performed as described above. Abundance andmelting curve of POLR2Awere determined by SDS-PAGE andwestern blot analysis.
In brief, 10 mg protein (based on the lowest temperature) were separated on 4%–15% precast polyacrylamide gels (Bio-Rad)
following the manual. Blotting was performed using the Trans-Blot TurboTM Transfer System (Bio-Rad) according to the instruc-
tions. For detection of total and phosphorylated POLR2A, Rpb1-specific antibodies (#2629 and #4735 for Ser2/5 phosphorylation,
Cell Signaling) were used and themanufacturer’s protocol followed. Chemiluminescence was recorded using the ChemiDoc imaging
system (Bio-Rad) and analyzed via Image Lab 5.2.1.
Tubulin heatshock and microscopy
HeLa Kyoto EGFP-alpha-tubulin/H2B-mCherry (Steigemann et al., 2009) were synchronized at the G1/S transition as done for the
parental cell line. After the second thymidine block, cells were released for 8 to 10 hours until most of them were in mitosis as deter-
mined by phase contrast microscopy. They were collected, washed, resuspended in PBS at 0.53 106 cells, and subjected to a heat
treatment as done for the thermal profiling andMS. Afterward they were fixedwith 4%PFA for 15min at room temperature. An aliquot
of each sample was let settle down onto a well of a CELLview slide (Greiner Bio-One) previously coated with poly-L-Lys. Cells were
imaged on an inverted Leica TCS SP8 STED3x microscope (Leica Microsystems, Mannheim, Germany), using a HC PL APO CS2
63x/1.40 OIL objective and a tuneable and pulsed White Light Laser (WLL, emission from 470-670nm). Standard, diffraction limited
confocal images were recorded for mRFP (594 nm, BP 600-690 nm) and EGFP (488 nm, BP 495-541 nm). z stacks were acquired to
cover the whole cell with a z-step size of 1 mm. Images were processed using the Fiji distribution of ImageJ (https://fiji.sc/).
Thermal profiling of recombinant RNAP II complex
RNAP II yeast strain was a gift from Mikhail Kashlev at the NIH/National Cancer Institute (NCI), Bethesda. Pol II was purified from
S. cerevisiae using aHis-tag purification protocol as previously described (Kireeva et al., 2003).WhenRNApol II was bound to nucleic
acids, then a 5-fold molar excess of a pre-annealed 38-bp transcription scaffold with a 20-nt RNA (50-UAUAUGCAUAAAGAC
CAGGC-30) as previously described (Tafur et al., 2016) was used. Briefly, the template (T) and non-template (NT) strands were mixed
and annealed by heating to 95C in RNase-free water, and then slowly cooled to 25C in 1 hr. Then, an equimolar amount of RNAwas
added and annealed by incubation at RT before addition of RNA pol II.
For the thermal profiling, aliquots of purified Pol II ± DNA/RNA scaffold were incubated for 3 minutes at the indicated temperature,
left at room temperature for 3 more minutes and the aggregated protein was removed by ultracentrifugation (20min at 100.000 xg
at 4C). The supernatant was used for Coomassie gel.
QUANTIFICATION AND STATISTICAL ANALYSES
MS computational analysis and normalization
Raw MS data was processed with IsobarQuant (Franken et al., 2015) and peptide and protein identification was performed with the
Mascot 2.4 (Matrix Science) search engine. Data was searched against a human database from Uniprot including known contami-
nants and the reversed protein sequences. Search parameters: trypsin, missed cleavages 3, peptide tolerance 10ppm, 0.02Da
for MS/MS tolerance. Fixed modifications were carbamidomethyl on cysteines and TMT10plex on lysine. Variable modificationsCell 173, 1495–1507.e1–e6, May 31, 2018 e4
included acetylation on protein N terminus, oxidation of methionine and TMT10plex on peptide N-termini. The programming lan-
guage R (https://www.r-project.org/) was used to analyze the raw output data from IsobarQuant (Franken et al., 2015).
Three independent datasets were processed in total (2D-TPP data, SDS data and TPP-TR data) using a similar base workflow as
described in the following: First, the output files of IsobarQuant were loaded into R and merged. The raw data was then saved in an
ExpressionSet R-object. Subsequently, potential batch effects were removed using limma (Ritchie et al., 2015) and data was normal-
ized using variance stabilization, vsn strategy (Huber et al., 2002). For each temperature, an independent normalization run was used
in order to account for the decreasing intensity of signal sums with increasing temperature. To calculate the abundance and stability
scores, we used a bootstrap algorithm; for calculating the expression scores, the results of the concordant limma analysis were
modified. For all scores, two different false discovery rates were estimated, a local and a global FDR. The global FDR was calculated
based on the score distribution (z-distribution) and thereby correlates with the effect size of the score. The local FDR, on the other
hand, describes the quality and the reproducibility of the score values and takes into account the variance between replicates.
Thermal proteome profiling (TPP) analysis
After normalization of the raw TPP-TR data, the TPP package (Franken et al., 2015) was used to identify melting points. After normal-
ization of the 2D-TPP dataset, fold changes were calculated against the respective 37C and the G1/S data points. These were used
for the calculation of abundance and stability scores.
For the SDS data, a limma analysis was performed on the normalized data by comparing each cell-cycle to the G1/S cell cycle. The
resulting fold changes (logFC) were transformed into z-scores using the Cox method (Cox and Mann, 2008) in order to determine
the expression scores for each protein. The global FDR for the expression score was calculated from the z-values using fdrtool
R package taking the q-value as the output. The local FDR for the expression score was calculated by adjusting the limma p values
for multiple testing by Benjamini & Hochberg with the p.adjust method (method = ’’fdr’’).
In order to calculate the abundance and stability scores, a bootstrap method was used with 500 iterations and a prerequisite of at
least 2 measured data points for the two lowest temperatures. In the bootstrap loop, one G1/S-ratio point out of the three replicates
for each temperature was chosen and used for the calculation. The abundance value was simply the average of the log2(G1/S.ratio)
for the first two temperatures (37 and 40.4C). The stability value was calculated by first subtracting the average log2(G1/S.ratio) of
the first temperatures from all log2(G1/S.ratios) of all temperatures and then calculating the sum of the resulting values. After
repeating this 500 times, each protein yields a distribution of abundance and stability values. From these distributions we calculated
the standard deviation and the average. Together with the number of data points that were considered for bootstrapping, we could
calculate a p value (transformation into z-scores and then assuming Student’s t-distribution) to estimate the likelihood that the
distribution is different from zero (no change).
The averages were transformed into the z-distribution which represent the new stability and abundance scores. The global FDR
was then calculated using the fdrtool package.
In order to make a call on significant hits based on these different scores, we chose a cut-off of 0.01 for the local, as well as the
global FDR for each cell-cycle and score.
Abundance, expression and stability score data were clustered using proteins that were detected with a significant change in at
least one of the different scores in one cell cycle stage. For each protein, each score for each cell cycle stage (18 features) were used
as features to calculate the euclidean distance. Using the Ward.D2 clustering method the results were divided into 21 different
clusters which captured most of the variability in the data.
For solubility experiments limma calculated p values for comparison between solubility in G1/S (abundance difference between
NP40 and SDS) and mitosis (abundance difference between NP40 and SDS) were calculated, and corrected using Benjamin-Hoch-
berg. An FDR cut-off of 0.05 was used, additionally an effect size of > 0.322 (25% regulation) was required for the log2 fold-changes,
and the solubility in G1/S had to be < 0.
Boxplots
The lower and the upper hinges of the boxes correspond to the 25% and the 75% percentile, and the bar in the box the median. The
upper and upper whiskers represent the largest and lowest values, respectively (but at maximum 1.5 times the IQR). Points outside
the whiskers are plotted individually. Group tests were performed using a nonparametric Wilcoxon test and statistical significance is
indicated by: * p% 0.05, ** p% 0.01 and *** p% 0.001 if not stated otherwise.
Reactome pathway analysis
All quantified proteins from this study were mapped to Reactome pathways (https://reactome.org/download-data/, February 2017)
using themygene-package in Python (https://pypi.python.org/pypi/mygene). For each pathway, corrected p values (local FDR) of all
its quantified protein components were combined using the Empirical Brownmethod (EBM) to account for dependent p values (Poole
et al., 2016). These combined p values were corrected using the Benjamini-Hochberg procedure. For pathway selection and visu-
alization, we considered those that were sufficiently covered (> 60% pathway coverage with 5-150 quantified protein members),
and had at least 30% of its protein components changing significantly in at least one cell cycle stage (local.FDR (stability) < 0.01).
106 pathways that passed these criteria were thenmanually curated for redundant proteins that changed significantly in several path-
ways, with 30 pathways retained in the end (visualized in Figure 2D; Table S5). If the combined adjusted p value for a pathway in ae5 Cell 173, 1495–1507.e1–e6, May 31, 2018
given stage was less than 0.05, full opacity is given; otherwise the bubble remains transparent. Overall tendency of a pathway to be
stabilized or destabilized was calculated as the median stability score of its significantly changing protein components (local.FDR
(stability) < 0.01) in each cell cycle stage.
Gene ontology analysis
Gene ontology analysis on proteins significantly affected during the cell cycle in either stability or abundance has been performed
with DAVID (version 6.7) (https://david.ncifcrf.gov/), based on GO terms ‘‘Biological Process,’’ ‘‘Molecular Function,’’ ‘‘Cellular
Compartment’’ and SP-PIR Keywords. All quantified proteins represented the corresponding background. Benjamini-Hochberg
corrected p values were used. For visualization purposes only GO-hits with an FDR < 0.05 were taken into account, and shown in
Figure S2C. For Figure 2E only the fold enrichment of the top-hits in each GO-category is shown for each of the 21 clusters.
Complex correlation analysis
Proteins were assigned to complexes defined by COMPLEAT and CORUM, as curated and published (Ori et al., 2016). Stability- as
well as abundance z-scores were concatenated for each protein, or remained separate vectors, respectively. Subunits of complexes
were correlated (Pearsonmethod) with subunits of the same complex; as a control, proteins not assigned to any complex were corre-
lated with other non-complex associated proteins.
Complex sub-clustering
For clustering complexes assigned as above stability as well as abundance z-scores were considered. The clustering was performed
using the k-medoids algorithm iterating from 2 to 5 potential clusters per complex, and the Euclidean distance between the
calculated medoids was monitored at each iteration step. For each complex then the maximum distance reflecting the best possible
clustering, is recovered.
Analysis of disordered proteins
To assess the nature and origin of the shift in melting points in mitosis relative to the reference, we took into account the disordered
state of a protein. The disordered state of each protein was described using the d2p2-database, which combines predictions of
several algorithms and makes calls on regions if they have been found to be disordered in at least 75% of those libraries (PONDR
VL-XT PONDR VSL2b, PrDOS, PV2, IUPred (+sub-versions of it), Espritz (+sub-versions if it)) (http://d2p2.pro/, February 2017).
The protein was ranked according to the relative number of amino acid residues that lie within supposed disordered regions spanning
a minimum of 5 amino acids. The relative disordered rank was also corrected taking into account known structural motifs that might
overlap with the predicted disordered region using the PDB (see Tables S6 and S7).
Mapping of proteins to posttranslational modifications
Modifications were extracted from the PhosphoSitePlus (https://www.phosphosite.org/homeAction.action, March 2017), containing
information on known acetylation, methylation, ubiquitination, sumoylation and phosphorylation sites. Proteins containing such sites
were scanned for stability and abundance patterns across the cell cycle stages. 512 mitotically regulated phosphorylation sites were
extracted from Olsen et al. (2010) (Tables S6 and S7: List of regulated mitotic phosphorylation sites with high occupancy).
Organelle/Compartment Analysis
Localization of a protein was defined by the GO-term (only Experimental Evidence is allowed, no inference from computational
methods) and the humanProteinAtlas (http://www.proteinatlas.org/, May 2017) using the data supported, validated or approved
by antibody-analysis. For the evaluation of the solubility transition data the humanProteinAtlas annotation was used as well as the
data from Wilkie et al. (2011) for nuclear envelope annotation.
DATA AND SOFTWARE AVAILABILITY
All analyzed data is made available in supplemental data files. Supplementary tables and clustering of individual complexes can be
found at Mendeley: https://doi.org/10.17632/xrbmvv5srs.2. TheMS proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identifier PXD008646. All code used for data analysis is available at
https://github.com/fstein/cellcycle_TPP.Cell 173, 1495–1507.e1–e6, May 31, 2018 e6
Supplemental Figures
Figure S1. Analysis of the Different Cell-Cycle Stages in Each Sample by Flow Cytometry, Related to Figures 1 and 2A
Representative images of the analysis used to quantify the amount of cells in G1-phase, S and mitosis. For all the analysis, the population of single cells with a 2n
and 4n DNA content was gated based on the PI staining (pulse area versus pulse width). The G0/G1 population is shown at 50K pulse area of PI signal; the G2/M
population, at 100K.
(legend continued on next page)
(A) Histograms of DNA content. The pulse area of the PI signal was fitted to a cell cycle distribution using the Watson pragmatic model approach in FlowJo v10.
The fitted populations in G1, S and G2/M stages are shown in blue, yellow and green, respectively.
(B) The population with a stronger PCNA signal was gated on asynchronous cells and considered as S-phase population. The same gate was applied to all other
samples.
(C) To quantify the mitotic population, cells positive for phospho-Histone H3 (Ser10) and with a G2/M DNA content were gated in the asynchronous sample; this
gate was subsequently applied to the rest of samples.
(D) Overview of the quantification of the three replicates used for the thermal profiling experiments (2D-TPP and TPP-TR) as well as SDS extracts. Themean ± SD
is shown.
(E) Heatmap for CCNA2 and CDK1, from which abundance and stability scores were calculated. The vertical direction indicates the increase in temperature and
the horizontal direction progress in cell cycle.
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(legend on next page)
Figure S2. Analysis of Cell-Cycle-Dependent Stability Effects on Organelle-Specific Proteins and Fine-Grained GO Results, Related to
Figure 2E
(A) Bar plots showing the ratio of organelle-specific proteins (as defined from gene ontology) affected in either stability or abundance or both.
(B) Heatmap showing ER-associated/localized proteins that are significantly affected in their abundance (left panel), stability (right panel) or both (middle panel)
during mitosis.
(C) GO-enrichment results from DAVID (https://david-d.ncifcrf.gov/) with the colors encoding different broad functional categories. The size of the bubble il-
lustrates the relative coverage of the respective GO-category, and the color of the bubbles shows the fold enrichment, x axis with the 21 clusters defined in
Figure 2E.
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Figure S3. Related to Figures 3B and 3C
(A) Circle plots for potential new cell cycle markers changing in their stability during the cell cycle (COMT, CBS/CBSL, PCYT1A).
(B) Knock-down of the proteins shown in A results in significant changes in percentage of cells in G1 and S (assessed after 4 days knock-down by PI staining and
flow cytometry).
(C) Knock-down of the proteins shown in A results in significant changes in percentage of live cells (assessed after 4 days knock/down using a cytotoxicity assay)
compared with siCTRL.
(D) Knock-down of the proteins shown in A results in minor changes in percentage of dead cells (assessed after 4 days knock/down using a cytotoxicity assay).
(E) Knock down efficiency on mRNA level (qPCR), two biological replicates.
(F) Knock down efficiency on protein level (mass spectrometry-based quantification), two biological replicates. SEM is shown.
Figure S4. Related to Figure 4
(A) Western blot images used for quantification of POLR2A destabilization upon 3h treatment with JQ1.
(B) Western blot images used for quantification of POLR2A destabilization upon 3h treatment with THZ1, as well as melting curve plot derived from this image.
(C) Western blot images used for quantification of phosphorylated POLR2A destabilization upon 3h treatment with JQ1.
(D) Quantification of (C). SEM is shown.
(E) Coomassie gel showing purified RNA Pol II complex from yeast. From left to right with increasing temperature, always control and treatment (+DNA) next to
each other. Blue numbers indicate the subunits separated on the gel.
(legend on next page)
Figure S5. Overview of Complex Co-stability and Co-abundance and Differential Stability Pattern of Moonlighting Subunits of the Exosome
Complex, Related to Figure 5
co-co-(A) Melting temperatures of same protein complexes in G1/S compared to random complex assignment.
(B) Scatterplot showing complex median co-abundance (median correlation calculated from abundance profiles of corresponding subunits) versus complex
median co-stability (median correlation calculated from stability profiles of corresponding subunits).
(C) Exosome structure with indicated catalytic subunits, DIS3 and EXOSC10 (light red). Density graph of correlation values (Pearson) calculated from concat-
enated abundance-stability profiles of all subunits of the Exosome complex, as well as the corresponding correlation matrix as designed for the NPC (see
Figure 6F).
(D) Correlation matrix of proteasome-subunits based on their concatenated abundance-stability profiles. The colors on the left indicate their association with a
specific sub-structure of the proteasome, as colored in the respective cartoon.
(E) Correlation matrix of condensin II-subunits based on their concatenated abundance-stability profiles. The colors on the left indicate their association with a
specific sub-structure of condensin II, as colored in the respective cartoon.
(F) Line plots for all measured subunits of the NPC-complex showing stability (purple), abundance (NP-40, orange) and abundance (SDS, green) scores.
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Figure S6. Related to Figure 6
(A) Melting curves for CHD4, KIF4A and SMARCA4A. Data shows the median for three replicates.
(B) Circle and line plots showing abundance (NP-40, orange) and stability scores (purple) for NUP358, CHD4, KIF4A and SMARAC4.
(C) Boxplot comparing melting temperatures inM, on the left are annotated spindle proteins from Sauer et al. The horizontal lines show themedian of non-spindle
proteins (black line) and spindle proteins (red line) indicating the lower melting temperatures of spindle proteins.
(D) Melting temperatures for G1/S and M. Proteins in red were selected for further GO analysis shown in (E).
(E) GO for spindle proteins shown in (D). GO analysis using DAVID (https://david-d.ncifcrf.gov/) was conducted on the protein set that is stabilized in mitosis
relative to the G1/S reference point. For filtering we considered proteins that were significantly stabilized (p value < 0.1) and with their melting point in mitosis
below 55C and in G1/S below 50C. The resulting 161 proteins were primarily found to be involved in DNA-binding activity and chromatin-associated processes.
The scatter illustrates the fold-enrichment against the respective FDR for terms derived from the broad categories ‘‘molecular function’’ and ‘‘biological pro-
cesses.’’ The size of each bubble relates to the number of proteins identified for each term.
(F) Difference in melting points (G1/S versus M) of all proteins, and proteins annotated with different post-translational modifications (specified in the STAR
Methods). SEM is shown.
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Figure S7. Related to Figure 7
(A) Scatterplot comparing the solubility of proteins in G1/S and the relative change in solubility of proteins in mitosis versus G1/S. Proteins with negative x axis
values and close to zero y axis values are insoluble in G1/S and remain insoluble in mitosis. Proteins with negative x axis values and positive y axis values are
insoluble in G1/S and become more soluble in mitosis.
(B) GO analysis using DAVID (https://david-d.ncifcrf.gov/) was conducted on the protein set that is significantly more soluble in mitosis versus G1/S. The scatter
illustrates the fold-enrichment against the respective FDR for terms derived from the broad category ‘‘molecular function.’’ The size of each bubble relates to the
number of proteins identified for each term.
(C) Solubility differences in mitosis versus G1/S of all proteins, and proteins annotated with different post-translational modifications (specified in the STAR
Methods). SEM is shown.
